Key Insights

Highlights

Success Rate

93% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

2.9%

2 terminated out of 68 trials

Success Rate

93.3%

+6.8% vs benchmark

Late-Stage Pipeline

10%

7 trials in Phase 3/4

Results Transparency

14%

4 of 28 completed with results

Key Signals

4 with results93% success

Data Visualizations

Phase Distribution

47Total
Not Applicable (36)
P 2 (4)
P 3 (1)
P 4 (6)

Trial Status

Completed28
Recruiting15
Unknown12
Active Not Recruiting5
Not Yet Recruiting3
Terminated2

Trial Success Rate

93.3%

Benchmark: 86.5%

Based on 28 completed trials

Clinical Trials (68)

Showing 20 of 20 trials
NCT07560813Not ApplicableNot Yet Recruiting

NOURISH - A Healthcare-community Partnership to Improve Nutrition for Optimal Glycemic Control and Pregnancy Outcomes With Pregestational Diabetes

NCT07293715Phase 4RecruitingPrimary

Permissive Versus Strict Intrapartum Glucose Management in Type 1 Diabetes (PRISM-T1D)

NCT07540585Not Yet Recruiting

MOCHA: Embedded Inpatient Mental Health Care for High-Risk Perinatal Patients

NCT05552053Phase 2Active Not Recruiting

Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women

NCT04542148Phase 2Active Not Recruiting

Glycemic Control After Antenatal Corticosteroids in Women With Pregestational and Gestational Diabetes

NCT06396078Phase 4Recruiting

Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)

NCT06445946Phase 4Recruiting

DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes

NCT06430853Not ApplicableEnrolling By Invitation

Psychobiological Interventions in Pregnancy

NCT05909046Not ApplicableRecruiting

A Randomized Controlled Trial of Diabetes Screening Immediately Postpartum (DIP) and Follow Up PP CARE

NCT04861103Phase 4RecruitingPrimary

Anticoagulation Profile in Pregnant Women Treated With Three Times a Day of Low Molecular Weight Heparin (LMWH)

NCT06490874Withdrawn

Continuous Glucose Monitoring (CGM) Substudy of the DECIDE RCT

NCT05790252Phase 3Recruiting

Transdermal Patch for BupRenorphine Induction DurinG PrEgnancy (Patch BRIDGE)

NCT07190157Not Yet Recruiting

Relationship of DV Doppler Parameters to Perinatal Outcomes in IUGR vs Non-IUGR

NCT05317585Not ApplicableRecruiting

Continuous Glucose Monitor Use in Pregnancy

NCT05887115Not ApplicableTerminatedPrimary

Nurse Family Partnership for Women With Previous Live Births

NCT05388643Not ApplicableRecruiting

Early Detection of Gestational Diabetes Mellitus in Pregnancy

NCT05739123Recruiting

Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their Offspring

NCT05124808Not ApplicableRecruiting

Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes

NCT05739136Active Not Recruiting

MYFEMBREE®: A Retrospective Cohort Study Using an Administrative Healthcare Database to Assess Pregnancy Outcomes in Women Treated With Relugolix Combination Therapy

NCT05922033Phase 4Completed

Patient Versus Provider-led Titration of Insulin for Glycemic Control in Gestational Diabetes (EMPOWER)

Scroll to load more

Research Network

Activity Timeline